MDPI and ACS Style
Jones, W.S.; Rice, S.; Power, H.M.; Maniatopoulos, G.; Suklan, J.; Beyer, F.; Wilcox, M.H.; Permain, M.; Simpson, A.J.; Price, D.A.;
et al. Cost Consequences for the NHS of Using a Two-Step Testing Method for the Detection of Clostridium difficile with a Point of Care, Polymerase Chain Reaction Test as the First Step. Diagnostics 2020, 10, 819.
https://doi.org/10.3390/diagnostics10100819
AMA Style
Jones WS, Rice S, Power HM, Maniatopoulos G, Suklan J, Beyer F, Wilcox MH, Permain M, Simpson AJ, Price DA,
et al. Cost Consequences for the NHS of Using a Two-Step Testing Method for the Detection of Clostridium difficile with a Point of Care, Polymerase Chain Reaction Test as the First Step. Diagnostics. 2020; 10(10):819.
https://doi.org/10.3390/diagnostics10100819
Chicago/Turabian Style
Jones, William S., Stephen Rice, H. Michael Power, Gregory Maniatopoulos, Jana Suklan, Fiona Beyer, Mark H. Wilcox, Michelle Permain, A. John Simpson, D. Ashley Price,
and et al. 2020. "Cost Consequences for the NHS of Using a Two-Step Testing Method for the Detection of Clostridium difficile with a Point of Care, Polymerase Chain Reaction Test as the First Step" Diagnostics 10, no. 10: 819.
https://doi.org/10.3390/diagnostics10100819